Technical Analysis for MPME - Medisun Precision Medicine Ltd.

Grade Last Price % Change Price Change
grade F 0.0003 0.00% 0.0000
MPME closed unchanged on Monday, October 14, 2019, on 1.85 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MPME trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for MPME ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Medisun Precision Medicine Ltd., a development stage company, focuses on developing targeted therapies primarily in the United States. It is developing ACX-31, a program to deliver temozolomide, a chemotherapy drug in combination with BCNU directly to brain tumor sites; and BranchPoint, a microinjection brain catheter for use in the delivery of therapeutics to the human brain. The company has a collaboration agreement with DelMar Pharmaceuticals, Inc. to develop ACX-31; and a consulting agreement with Lim Development Group to develop and commercialize the BranchPoint device. The company was formerly known as Accurexa, Inc. and changed its name to Medisun Precision Medicine Ltd. in June 2017. Medisun Precision Medicine Ltd. was incorporated in 2012 and is based in Majuro, the Republic of the Marshall Islands.
Medicine RTT Cancer Clinical Medicine Chemotherapy Oncology Cancer Treatments Brain Tumor
Is MPME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.3293
52 Week Low 0.0003
Average Volume 14,052
200-Day Moving Average 0.0867
50-Day Moving Average 0.0388
20-Day Moving Average 0.024
10-Day Moving Average 0.015
Average True Range 0.0054
ADX 14.86
+DI 33.6927
-DI 57.8167
Chandelier Exit (Long, 3 ATRs ) 0.05380000000000001
Chandelier Exit (Short, 3 ATRs ) 0.0165
Upper Bollinger Band 0.0496
Lower Bollinger Band -0.0016
Percent B (%b) 0.04
BandWidth 213.333333
MACD Line -0.0095
MACD Signal Line -0.0076
MACD Histogram -0.0019
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0003
Resistance 3 (R3) 0.0003 0.0003 0.0003
Resistance 2 (R2) 0.0003 0.0003 0.0003 0.0003
Resistance 1 (R1) 0.0003 0.0003 0.0003 0.0003 0.0003
Pivot Point 0.0003 0.0003 0.0003 0.0003 0.0003
Support 1 (S1) 0.0003 0.0003 0.0003 0.0003 0.0003
Support 2 (S2) 0.0003 0.0003 0.0003 0.0003
Support 3 (S3) 0.0003 0.0003 0.0003
Support 4 (S4) 0.0003